(0.13%) 5 187.70 points
(0.08%) 38 884 points
(-0.10%) 16 333 points
(-0.37%) $78.09
(0.41%) $2.22
(-0.18%) $2 320.10
(-0.41%) $27.43
(-0.03%) $988.10
(0.14%) $0.931
(0.38%) $10.94
(0.13%) $0.800
(0.00%) $91.44
-1.90% $ 8.77
@ $7.28
Wydano: 14 vas. 2024 @ 16:30
Zwrot: 20.47%
Poprzedni sygnał: vas. 13 - 16:30
Poprzedni sygnał:
Zwrot: -1.38 %
Live Chart Being Loaded With Signals
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease...
Stats | |
---|---|
Dzisiejszy wolumen | 385 634 |
Średni wolumen | 672 922 |
Kapitalizacja rynkowa | 476.22M |
EPS | $0 ( 2024-02-28 ) |
Następna data zysków | ( $-0.440 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 2.95 |
ATR14 | $0.00800 (0.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Ferguson Toby | Buy | 105 000 | Common Stock |
2024-04-02 | Swartz Robin | Sell | 1 357 | Common Stock |
2024-04-02 | Sandrock Alfred | Sell | 12 115 | Common Stock |
2024-03-25 | Ferguson Toby | Buy | 210 000 | Stock Option (Right to Buy) |
2024-03-25 | Ferguson Toby | Buy | 0 |
INSIDER POWER |
---|
44.74 |
Last 94 transactions |
Buy: 7 546 876 | Sell: 3 757 926 |
Wolumen Korelacja
Voyager Therapeutics Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
DYNT | 0.929 |
DGLY | 0.909 |
CRNC | 0.909 |
ATNX | 0.905 |
GFAI | 0.905 |
LIVE | 0.897 |
FTFT | 0.896 |
ECOR | 0.896 |
CFRX | 0.889 |
APRE | 0.886 |
10 Najbardziej negatywne korelacje | |
---|---|
MTEX | -0.862 |
ZENV | -0.859 |
VERA | -0.852 |
GRIN | -0.848 |
GRPH | -0.843 |
DSPC | -0.835 |
JAN | -0.832 |
RIVN | -0.831 |
LAWS | -0.827 |
VERX | -0.826 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Voyager Therapeutics Inc Korelacja - Waluta/Towar
Voyager Therapeutics Inc Finanse
Annual | 2023 |
Przychody: | $250.01M |
Zysk brutto: | $245.57M (98.22 %) |
EPS: | $3.08 |
FY | 2023 |
Przychody: | $250.01M |
Zysk brutto: | $245.57M (98.22 %) |
EPS: | $3.08 |
FY | 2022 |
Przychody: | $40.91M |
Zysk brutto: | $34.72M (84.87 %) |
EPS: | $-1.210 |
FY | 2021 |
Przychody: | $37.42M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.890 |
Financial Reports:
No articles found.
Voyager Therapeutics Inc
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau program for the treatment of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, as well as for spinal muscular atrophy. The company has collaboration and license agreements with Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. for the research, development, and commercialization of adeno-associated virus gene therapy products. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej